⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KRYS News
Krystal Biotech, Inc. Common Stock
Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call
globenewswire.com
CRBP
KRYS
Form 8-K
sec.gov
KRYS
Krystal Biotech Announces United Kingdom MHRA Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
globenewswire.com
KRYS
Krystal Biotech to Present at BofA Securities 2026 Health Care Conference
globenewswire.com
KRYS
Form 8-K
sec.gov
KRYS
Krystal Biotech Announces First Quarter 2026 Financial and Operating Results
globenewswire.com
KRYS
Krystal Biotech to Present at Upcoming Scientific Conferences
globenewswire.com
KRYS
Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026
globenewswire.com
KRYS
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
globenewswire.com
PVLA
KRYS
VYJUVEK (Krystal Biotech) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
KRYS